Illumina accused of fraud in DNA tech patents dispute
12-01-2021
Duncan_Andison / iStockphoto.com
Genetic sequencing company Illumina and Cornell University have together sought to dismiss a patent dispute over eight genetic testing patents belonging to Cornell.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Illumina, Cornell University, Life Technologies, gene sequencing, patent, agreement
